Fulgent Genetics FLGT
NASDAQ FLGT
$19.93 +0.12 (+0.61%)
As of: Aug 27, 2026 · 3:59 PM EDT

Fulgent Genetics (FLGT) Restructuring Costs (2022 - 2026)

Fulgent Genetics (FLGT) posted Restructuring Costs of $300000.0 for Q2 2026, down 88.46% sequentially from $2.6 million in Q1 2026.

Fulgent Genetics (FLGT) Restructuring Costs (2022 - 2026) Analysis & Trends

Fulgent Genetics has reported Restructuring Costs for 2 years, with the latest figure at $300000.0 in Q2 2026.

  • Quarterly Restructuring Costs changed N/A year-over-year to $300000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $6.5 million (changed N/A YoY) and the FY2025 annual result came in at $1.5 million, changed N/A from the prior year.
  • Restructuring Costs declined to $300000.0 in Q2 2026 per FLGT's latest filing, from $2.6 million in the prior quarter.
  • Over five years, Restructuring Costs peaked at $2.6 million in Q1 2026 and troughed at $300000.0 in Q2 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn
10 Fulgent Genetics 557.44 Mn 300.41 Mn 25.68 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 300,000.00
Mar 31, 2026 2.60 Mn
Dec 31, 2025 1.50 Mn
Sep 30, 2025 2.10 Mn
Dec 31, 2022 -26,000.00
Sep 30, 2022 105,000.00
Jun 30, 2022 2.90 Mn